Mark van Oene - 17 Aug 2026 Form 4 Insider Report for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)

Reporting relationship: President & CEO
Issuer ticker: PACB
Reported as of: 17 Aug 2026
Net transaction value: -$30,409
SEC form: 4
Accepted by SEC: 18 Aug 2026, 20:17:35 UTC
Prior SEC filing: 11 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Brett Atkins, Attorney-in-fact

Key filing fact

Mark van Oene filed Form 4 for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) on 18 Aug 2026.

Key facts

This page summarizes Mark van Oene's Form 4 filing for PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 18 Aug 2026, 20:17.

Change

Previous filing in this sequence was filed on 11 Aug 2026.
Current net transaction value: -$30,409.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001707477 Primary reporting owner

Van Oene Mark

Relationship: President & CEO
Address: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.,, 1305 O'BRIEN DRIVE, MENLO PARK
Signature: /s/ Brett Atkins, Attorney-in-fact
Signature date: 18 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PACB transaction

Common Stock

Sale

Transaction value: $30,409
Shares: -26,911
Change %: -0.98%
Price: $1.13
Shares after: 2,705,853
Date: 17 Aug 2026
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Footnote F2

This sale price represents the weighted average sale price of the shares sold ranging from $1.13 to $1.15 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.

SEC remarks

President & CEO